All American® Pharmaceutical Announces Expansion

FASEB Conference 2014
August 11, 2014
EFX Sports™ Partners With Billings Wolves Football
November 7, 2014
Show all

All American® Pharmaceutical Announces Expansion


Coupled with the recent announcement that they will be doing clinical studies on one of their products to gauge its impact for pre-diabetic individuals, All American Pharmaceutical & Natural Food Corporation (AAP) also received approval on a grant application to reduce costs for expansion, by the board of the Big Sky Economic Development Authority (EDA). AAP plans to invest $650,000 in new equipment and staffing at their location at 2375 Main Street.

As a contract manufacturer of dietary supplements, AAP is researching the impact their product, KarboLyn®, has on glucose response in normal, and pre-diabetic adults during aerobic activity.

The clinical study will be headed by Dr. Thomas Harman, a former Family Medicine Department chairman at the Mayo Clinic in Rochester, Minnesota.

AAP has applied for a $180,000 grant from Big Sky Economic Development Trust Fund, Category 1 Grant.

We are a contract manufacturer who transforms raw materials into dietary supplements that create trust, loyalty, and repeat sales.

Comments are closed.